The objective of this Phase 1 study is to determine the safety and tolerability of OLX10212 in patients with advanced AMD at multiple sites in the US.
_256_384.jpg){kind=logo}
Meets the growing need for US-based API solubility and bioavailability enhancement services
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
The total covered market size of four brands – Z&D, Pediclory, Pecef & Ezinapi combined is Rs 1800 crores
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
The Congress was held on June, 20-21, 2022 in Berlin, Germany
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
Subscribe To Our Newsletter & Stay Updated
